Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk (CROSBI ID 213407)
Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija
Podaci o odgovornosti
Ehret, Georg B. ; ... ; Rudan, Igor ; ... : Zelenika, Diana ; ... ; Terzić, Janoš ; ... ; Polašek, Ozren ; ...
engleski
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk
Blood pressure (BP) is a heritable trait1 influenced by multiple biological pathways and is responsive to environmental stimuli. Over one billion people worldwide have hypertension (BP ≥140 mm Hg systolic [SBP] or ≥90 mm Hg diastolic [DBP])2. Even small increments in BP are associated with increased risk of cardiovascular events3. This genome-wide association study of SBP and DBP, which used a multi-stage design in 200, 000 individuals of European descent, identified 16 novel loci: six of these loci contain genes previously known or suspected to regulate BP (GUCY1A3-GUCY1B3 ; NPR3-C5orf23 ; ADM ; FURIN-FES ; GOSR2 ; GNAS-EDN3) ; the other 10 provide new clues to BP physiology. A genetic risk score based on 29 genome-wide significant variants was associated with hypertension, left ventricular wall thickness, stroke, and coronary artery disease, but not kidney disease or kidney function. We also observed associations with BP in East Asian, South Asian, and African ancestry individuals. Our findings provide new insights into the genetics and biology of BP, and suggest novel potential therapeutic pathways for cardiovascular disease prevention.
genes; blood pressure; cardiovascular disease risk
The International Consortium for Blood Pressure Genome-Wide Association Studies.
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
Povezanost rada
Kliničke medicinske znanosti